Economic realities: Pharma leadership is often conditioned for the "high-risk, high-reward" physics of pipeline assets. MedTech operates on iterative innovation and service-heavy models. Bridging ...
Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026 ...
PharmTech is rebranding to strengthen its commitment to scientists, innovators, and executives in the pharmaceutical industry ...
As pharmaceutical markets become more specialized and competitive, commercial and medical affairs teams must use technology and collaboration to make faster, better-informed decisions, Lance Hill, ...
When patients are prescribed complex therapies — like specialty drugs, cell and gene treatments, or high-cost biologics — the path to treatment is rarely straightforward. Filling a prescription can ...
Suzhou Zion Pharma Technology Co Ltd. has identified KRAS inhibitors, in particular GTPase KRAS G12D mutant and/or G13D mutant, reported to be useful for the treatment of cancer. Suzhou Zion Pharma ...
New global study of 250 pharma leaders shows rapid uptake of agentic AI; early adopters focus on market intelligence, patient support, compliance and data integration. As the industry seeks to grasp ...
Mitsubishi Tanabe Pharma filed a patent infringement lawsuit against Shanghai Auzone Biological Technology and its subsidiaries on Oct. 15 in New Jersey District Court. The action, which pertains to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results